NDC11 62332019030
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 62332-0190-30 | 62332-0190 |
| 62332-190-30 | 62332-190 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Febuxostat | FEBUXOSTAT | Alembic Pharmaceuticals Inc. | 9a87099f-d82d-42c7-872a-b87d3917e960 | 2023-04-27 | Boxed warning, Warnings, Adverse reactions | 62332-190-30 62332-190 62332019030 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.